Parkinson's disease (PD) is a motor system disorder caused by factors that lead to depletion of dopamine from the dopaminergic neurons in the substantia nigra. Mechanisms of PD include mitochondrial dysfunction, oxidative stress and neuroinflammation. Metformin is an old antidiabetic drug that has recently been shown to offer protective effects against many types of cancer, cardiovascular and neurodegenerative diseases. Indole-3-carbinol (I3C) is a phytochemical derived from the cruciform vegetables. Recently, I3C was proven to have antioxidant, anti-inflammatory and neuroprotective properties. The aim of this work was to study the effect of metformin and/or I3C on 6-hydroxydopamine (6-OHDA)-induced PD in rats. Sixty male Wistar rats were divided into 6 equal groups: Control; 6-OHDA, metformin + 6-OHDA; I3C + 6-OHDA; carboxymethyl cellulose + 6-OHDA and metformin + I3C + 6-OHDA group. Striatal dopamine, tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), transforming growth factor beta1 (TGF-β1), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione reductase (GR), mitochondrial complex 1 activity, total swim score and catalepsy score were measured. The striatum was subjected to immunohistochemical examination. The combination between metformin and I3C induced significant increase in striatal SOD, GR, mitochondrial complex 1 activity and dopamine with significant decrease in striatal TNF-α, IL-6, TGF-β1, MDA and nuclear factor kappa-B expression with significant improvement in catalepsy and total swim scores better than the groups that received either I3C or metformin alone. So, metformin/I3C combination may represent a beneficial therapeutic modality for amelioration of 6-OHDAinduced PD in rats..
INTRODUCTION
Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide affecting about 1% of the patients older than 60 years [1] . PD is usually precipitated by death of the dopaminergic neurons in the basal ganglia [2] .
Up till now, the mechanisms underlying the pathogenesis of PD have not yet been completely elucidated. However, these molecular mechanisms were thought to include mitochondrial dysfunction, oxidative stress, neuroinflammation and affection of apoptosis [3] .
In the past few decades, animal models of PD were used to explore the pathogenesis and find new therapeutic strategies for this neurodegenerative disease. Generally, these models are based on systemic or local administration of neutoxins that are able to produce most of the pathological and phenotypic features of PD [4] . These models include 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine model, 6-hydroxydopamine (6-OHDA) model, paraquat model, rotenone model and genetic models [5] . Intracerebral injection of 6-OHDA may induce mitochondrial dysfunction of dopaminergic neurons in the basal ganglia via inhibition of the activity of mitochondrial respiratory chain complex I and IV and reduction of the mitochondrial membrane potential [6] .
Moreover, 6-OHDA undergoes metabolic degradation producing free radicals that cause lipid peroxidation and DNA oxidation resulting in oxidative stress and neuroinflammation [7] . Also, 6-OHDA may disrupt the balance between the excitatory and inhibitory neurotransmitters in the brain leading to precipitation of some of the characteristic features of PD [8] .
Metformin is an euglycemic drug that was used over years for management of diabetes mellitus. It decreases intestinal absorption of glucose and increases its anaerobic oxidation.
Moreover, metformin increases the sensitivity of insulin receptors and decreases glucagon release [9] . Recent reports suggest that metformin may have neuroprotective effects against many neurodegenerative disorders [10, 11] . These effects may be attributed to the antioxidant and antiinflammatory properties of metformin together with its ability to restore mitochondrial functions and inhibit apoptosis [12] .
Indole-3-carbinol (I3C) is one of the indole compounds that are found in cruciferous vegetables, such as broccoli, which is formed by enzymatic breakdown of glucosinolate glucobrassicin by myrosinase [13] . Several reports indicated that I3C has potent antioxidant effects, possibly through decreased production of reactive oxygen species (ROS) and acting as free radical scavenger [14] . Also, I3C was proven to inhibit the inflammatory cascade at the gene expression level [15] . These properties together with the ability of I3C to decrease the expression of neuron specific enolase and increase monoamines levels in the brain may make I3C to represent a promising hope for management of neurological disorders [16] . The aim of this work was to clarify whether metformin and/or I3C has an effect on 6-OHDA-induced PD in rats and to explore the possible mechanisms of this effect.
Materials and Methods

Chemicals and drugs
Metformin Metformin was freshly dissolved in distilled water.
I3C was suspended in 0.5% CMC solution.
Animals
This study was performed on 60 
Groups
Rats were divided randomly into six equal groups each of 10 rats as follows:
Group I: Control group received a single injection of 4µl 1% ascorbic acid containing saline in the left substantia nigra.
Group II: Received a single intranigral injection of 6-OHDA as described above.
Group III: Received metformin in a dose of 150 mg/kg/day orally for one week before and continued for 4 weeks after intranigral injection of 6-OHDA [18] .
Group IV: Received I3C in a dose of 50 mg/kg/day orally for one week before and continued for 4
weeks after intranigral injection of 6-OHDA [16] .
Group V: Received 0.5 % CMC daily orally for one
week before and continued for 4 weeks after intranigral injection of 6-OHDA.
Group VI: Received metformin concomitantly with I3C daily orally in the above-mentioned doses for one week before and continued for 4 weeks after intranigral injection of 6-OHDA.
Assessment of the behavioral changes
The development of PD was assessed at 28 days from injection of 6-OHDA, by occurrence of tremors, bradykinesia and rigidity in rats that was further quantified by catalepsy score. The first part was the grid test where the rat was hung by its paws on a vertical grid and the time needed for the rat to move its paws or any sort of first movement was recorded. The second part of the test was the bar test where the rat was placed with both forepaws on a bar and the time of removal of the paw was observed and recorded [19] . Also, the swimming ability test was carried out using tubes with 12 cm high water maintained at 25 ± 3 ºC. Rats were placed in water and the swimming ability was recorded every minute for 10 minutes as follows: 3continuous swimming, 2-swimming with occasional floating, 1-more floating with occasional swimming with hind limbs, and 0-hind part sinks with only the head floating [20] .
At the end of the study, rats were killed by decapitation and the brain of each rat was immediately excised, washed with ice-cold saline and freezed at −70 °C. Then, the striata of the two hemispheres were isolated and weighed. One striatum was homogenized, centrifuged and the supernatant was used for estimation of the biochemical parameters and the other striatum was prepared for immunohistochemical examination of nuclear factor kappa B (NF-κB) expression.
Determination of striatal dopamine, superoxide dismutase (SOD), glutathione reductase (GR) and thiobarbituric acid derivatives (TBARS)
Dopamine levels were measured in the striatal tissues using ELISA kits supplied by USCN 
Statistical analysis
The measured values were expressed as mean ± standard error of mean (SEM). One way analysis of variance (ANOVA) was used to test significance of the difference among more than two arithmetic means followed by Scheffe test to test the difference between each two means. The significance of the results was considered at pvalues less than 0.05.
Results
Effect of different treatments on the behavioral tests
Administration of 6-OHDA induced significant increase in catalepsy score of either grid test or bar test with significant decrease in the total swim score compared to the control group.
Administration of metformin and/or I3C induced significant decrease in catalepsy score associated with significant increase in the total swim score compared to rats treated with 6-OHDA alone.
Administration of CMC induced non-significant effect on catalepsy and total swim scores compared to rats treated with 6-OHDA alone. Concomitant administration of metformin and I3C induced significant decrease in catalepsy score and significant increase in the total swim score compared to the use of each of these drugs alone (Table 1 , Fig. 1 ). . (Table 2) . . 
Effect of different treatments on
Effect of different treatments on mitochondrial complex I activity
Effect of different treatments on striatal TGF-β1, TNF-α and IL-6
Administration of 6-OHDA induced significant increase in striatal TGF-β1, TNF-α and IL-6 levels compared to the control group.
Administration of metformin and/or I3C induced significant decrease in striatal TGF-β1, TNF-α and IL-6 levels compared to rats treated with 6-OHDA alone. Administration of CMC induced nonsignificant effect on the above-mentioned parameters compared to rats treated with 6-OHDA alone. Concomitant administration of metformin and I3C induced significant decrease in striatal TGF-β1, TNF-α and IL-6 levels compared to the use of each of these drugs alone (Table 3) . the use of each of these drugs alone (Fig. 3,4 ). NF-κB is considered to be the "master switch" of the inflammatory cascade that is frequently encountered in PD [33] . NF-κB was proven to regulate the genes that regulate the expression of the proinflammatory cytokines and cell adhesion molecules. Also, the cross talk between NF-κB and TGF-β1 expression leads to increased generation of TNF-α, IL-6 and ROS in the substantia nigra which in turn leads to massive degeneration of the dopaminergic neurons [34] .
Effect of different treatments on NF-kB (p65)
Discussion
Also, it was proven that overexpression of TGF-β1 in the nigrostriatal system increases the dopaminergic deficit of PD and aggravates the parkinsonian state [35] . In the present study, the combination between metformin and I3C induced significant increase in striatal antioxidant enzymes, mitochondrial complex 1 activity and dopamine with significant decrease in striatal proinflammatory cytokines, TGF-β1, MDA and NF-κB expression with significant improvement in catalepsy and total swim scores better than the groups that received either I3C or metformin alone.
This might be due to the combined antioxidant and anti-inflammatory properties of both agents together with their ability to restore dopamine levels and mitochondrial functions in the brain tissues. It was reported that P-glycoprotein mediated efflux limits the transport of the antiparkinsonian drugs through the blood brain barrier [40] . Being an effective inhibitor of P-glycoprotein, I3C may decrease efflux of metformin and so may potentiate its anti-parkinsonian effects [41].
Conclusion
Metformin/I3C combination may represent a beneficial therapeutic modality for amelioration of 6-OHDA-induced PD in rats. This may be due to their antioxidant and antiinflammatory properties together with their abilities to restore mitochondrial functions and the ability of I3C to inhibit P-glycoprotein mediated efflux of metformin outside the brain tissues. Further studies are needed to explore the exact molecular mechanisms that underlie these effects.
Limitations of the study
The small sample size and the limited financial resources were the main limitations of this study.
